Status:

UNKNOWN

Gastric Venous Reconstruction After Total Pancreatectomy

Lead Sponsor:

University Hospital Heidelberg

Conditions:

Pancreas Cancer

Pancreatectomy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Total pancreatoduodenectomy (TP) is the standard surgical approach for treatment of extended pancreas tumors. If the gastric coronary vein has to be sacrificed for oncologic or for technical reasons i...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Provide written informed consent
  • Elective total pancreatectomy for malignant or benign pancreatic lesions or chronic pancreatitis with splenectomy
  • Intraoperative ligation of coronary vein

Exclusion

  • Gastric resection due to malignant infiltration
  • Non-reconstructable gastric venous drainage
  • Previous pancreas surgery

Key Trial Info

Start Date :

February 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04850430

Start Date

February 1 2024

End Date

December 1 2025

Last Update

December 13 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Surgery clinic

Heidelberg, Germany, 69493

2

Professor Dr. med. Arianeb Mehrabi

Heidelberg, Germany